cerrar
Tagged with Rare Disease

Interview: Wolfgang Schnitzel – General Manager; Karl-Heinz…
Dr. Wolfgang Schnitzel, general manager of Shire Austria, and Karl-Heinz Hofbauer, site lead Vienna and managing director for the Technical Operations…

Interview: Gianfranco Biliotti – General Manager, Alexion…
Gianfranco Biliotti, recently appointed General Manager for Alexion Colombia, shares his insights on the particularities of operating in the…

Christos Dakas – Managing Director, Shire Greece &…
A strong proponent of the value of orphan drugs, Shire Greece’s Managing Director, Christos Dakas, shares his insights on the recent merger with…

Interview: James Lennertz – Group VP and GM (EUMEA),…
James Lennertz, Group VP and GM EUMEA for BioMarin, discusses the key highlights of the past few years for BioMarin, their unique positioning as a…

Christophe Bourdon – SVP EMEA, Alexion Pharmaceuticals
Specializing in ultra-rare diseases, Alexion targets patient populations of less than 20 patients per million. Christophe Bourdon discusses…

Interview: Leonardo Torres – General Manager Mexico,…
Leonardo Torres, general manager Mexico, Central America & Caribbean of Shire, provides insights into the rapidly progressing integration of…

Interview: Dr. Andrea Michael Meyer – General Manager,…
Dr. Andrea Michael Meyer, general manager of Sanofi Genzyme Switzerland, reveals how the Swiss business has been experiencing year-on-year…

Interview: Elena Strapkova Boydova – Country Director,…
Biogen Slovakia's Country Director on being an innovative global biotech in Slovakia, market access in the country, and the company's commitment to…

Interview: Julie O’Neill – Executive Vice President,…
Julie O’Neill, Alexion’s EVP for Global Operations highlights Alexion’s establishment of its Global Supply Chain headquarters in Dublin,…

Interview: Fabio Andreola – Country Managing Director,…
Ahead of the imminent acquisition of Baxalta by Shire, country managing director Italy Fabio Andreola shares his perspective on the rare-disease…

Interview: Francesco Scopesi – VP & General Manager,…
Shire Italy's Francesco Scopesi discusses innovative medicine, rare diseases, growth drivers, global strategy, and the new trend of home care.…

Interview: Karel Fol – Country Manager Benelux, Sobi, The…
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here